Atlas Trials

The Impact of Communication With Healthcare Providers Via WeChat on Survival Outcomes for Lung Cancer Patietns

Clinical trial NCT06592430 · NOT_YET_RECRUITING

Trial details

NCT number
NCT06592430
Sponsor
Shanghai Pulmonary Hospital, Shanghai, China
Status
NOT_YET_RECRUITING
Study type
OBSERVATIONAL
Lung Cancer
Start date
2024-10-01
Primary completion
2025-10-01
Enrollment
2000

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.